Biotech | May 23, 2022
Soligenix receives US patent allowance for its thermostabilized vaccine platform
Includes thermostabilized Ebola vaccines
Includes thermostabilized Ebola vaccines
Immune response confirmed in stand-alone influenza vaccine and combination vaccine with a potential path forward for both
The peptide-based vaccine induces a t cell-dependent response
Both mRNA-1020 and mRNA-1030 target hemagglutinin and neuraminidase antigens, two major influenza surface glycoproteins that are essential across the viral life cycle
Collaboration to target bacterial and viral pathogens including HIV, SARS-CoV-2, antimicrobial-resistant pathogens, and tuberculosis
Under the agreement, Technology Development Board and Bharat Biotech have pledged the support of Rs.200 crore each to create a continuous corpus of Rs.400 crores for the project
Medicago and GSK collaborated on Covifenz, an adjuvanted plant-based vaccine
UNICOR-v has the potential to protect against future epidemics caused by a coronavirus jumping from animals to humans, but also against new variants emerging from SARS-Cov-2
CEPI is accelerating its programme to develop broadly protective coronavirus vaccines—a core part of US $ 3.5 billion pandemic preparedness plan
Effectiveness of Covaxin against the Omicron variant is currently being studied
Subscribe To Our Newsletter & Stay Updated
